You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

 

CME / ABIM MOC / CE

CDC Reveals Vaping Up Among Teenagers

  • Authors: News Author: Troy Brown, RN; CME Author: Laurie Barclay, MD
  • CME / ABIM MOC / CE Released: 10/30/2020
  • THIS ACTIVITY HAS EXPIRED FOR CREDIT
  • Valid for credit through: 10/30/2021, 11:59 PM EST
Start Activity


Target Audience and Goal Statement

This article is intended for internists, pulmonologists, pediatricians, emergency medicine clinicians, family practitioners, primary care clinicians, obstetricians/gynecologists/women's health practitioners, nurses, and other members of the health care team who treat and manage adolescents involved in vaping.

The goal of this activity is to provide medical news to primary care clinicians and other healthcare professionals in order to enhance patient care.

Upon completion of this activity, participants will be able to:

  • Assess use of tobacco, including cigarettes and electronic vapor products, among US high school students, based on an analysis of data from the 2019 Youth Risk Behavior Survey
  • Evaluate clinical implications of use of tobacco, including cigarettes and electronic vapor products, among US high school students, based on an analysis of data from the 2019 Youth Risk Behavior Survey
  • Outline implications for the healthcare team


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


News Author

  • Troy Brown, RN

    Freelance writer, Medscape

    Disclosures

    Disclosure: Troy Brown, RN, has disclosed no relevant financial relationships.

CME Author

  • Laurie Barclay, MD

    Freelance writer and reviewer, Medscape, LLC

    Disclosures

    Disclosure: Laurie Barclay, MD, has disclosed no relevant financial relationships.

Editor/CME Reviewer

  • Stephanie Corder, ND, RN, CHCP

    Associate Director, Accreditation and Compliance
    Medscape, LLC

    Disclosures

    Disclosure: Stephanie Corder, ND, RN, CHCP, has disclosed no relevant financial relationships.  

Nurse Planner

  • Hazel Dennison, DNP, RN, FNP-BC, CHCP, CPHQ, CNE

    Associate Director, Accreditation and Compliance
    Medscape, LLC

    Disclosures

    Disclosure: Hazel Dennison, DNP, RN, FNP-BC, CHCP, CPHQ, CNE, has disclosed no relevant financial relationships.

Medscape staff have disclosed that they have no relevant financial relationships.


Accreditation Statements

Medscape

Interprofessional Continuing Education

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

IPCE

This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit for learning and change.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    Contact This Provider

    For Nurses

  • Awarded 0.25 contact hour(s) of continuing nursing education for RNs and APNs; none of these credits is in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

CDC Reveals Vaping Up Among Teenagers

Authors: News Author: Troy Brown, RN; CME Author: Laurie Barclay, MDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME / ABIM MOC / CE Released: 10/30/2020

Valid for credit through: 10/30/2021, 11:59 PM EST

processing....

Clinical Context

In the United States, use of tobacco products is the leading cause of preventable disease, disability, and death. Approximately 88% of adults who smoke cigarettes daily report first trying cigarette smoking before 18 years of age. Although recent research suggests decreases in current cigarette smoking among US high school students, there is now available an increasing variety of electronic vapor products (eg, e-cigarettes) with growing popularity among youths.

A Centers for Disease Control and Prevention (CDC) report used data from the 2019 Youth Risk Behavior Survey to evaluate use of cigarettes and electronic vapor products among US high school students.

Study Synopsis and Perspective

Use of electronic vapor products, or vaping, more than doubled among US high school students from 2017 to 2019 (going from 13.2% in 2017 to 32.7% in 2019), a report from the CDC has found. Current cigarette smoking decreased from 8.8% to 6.0% during that time, as did cigar smoking (from 8.0% to 5.7%) and smokeless tobacco use (from 5.5% to 3.8%).

Current use of any tobacco product increased from 19.5% in 2017 to 36.5% in 2019.

"The dramatic increase in electronic vapor product use among high school students has led to increases in overall tobacco product use among U.S. youths, erasing gains made in previous years and leading the U.S. Surgeon General to declare youth e-cigarette use an epidemic in the United States," the authors write.

"The new youth tobacco use data released today from CDC's 2019 Youth Risk Behavior Survey confirm that our nation is facing multiple public health crises simultaneously: the COVID-19 pandemic, continued racial health equity disparities, and a youth vaping crisis," Harold Wimmer, president and chief executive office of the American Lung Association, said in a statement about the findings.

"The dramatic increase in youth vaping led to a near doubling of overall tobacco product use among high school students from 19.5% in 2017 to 36.5% in 2019," he added.

MeLisa R. Creamer, PhD, from the Office on Smoking and Health in the CDC's National Center for Chronic Disease Prevention and Health Promotion, and colleagues report their findings in an article published online August 20 in the Morbidity and Mortality Weekly Report.

The researchers analyzed data from the 1991 to 2019 cycles of the CDC's biennial national Youth Risk Behavior Survey. The findings, the authors say, are in line with those from other national surveillance systems, including the National Youth Tobacco Survey and Monitoring the Future.

Frequent use (20 or more days during the previous 30 days) of electronic vapor products also increased among current electronic vapor product users (from 25.1% to 32.6%), but frequent cigarette smoking fell and frequent use of smokeless tobacco or cigars remained the same among users of those products.

The use of 2 or more tobacco products did not change from 2017 to 2019. "Multiple tobacco product use is associated with substance use disorders and might increase nicotine exposure and risk for nicotine dependence," the authors explain.

Differences by Demographic Group

Among current vapers, the usual source of obtaining these products differed by age. Those aged 17 years or younger most often said they borrowed them from someone else (42.8%). Among those aged 18 or older, 56.4% said they purchased them in a store.

Federal legislation raised the minimum age for tobacco product sales from 18 to 21 years nationwide on December 20, 2019.

Students aged 17 years or younger were more likely to get tobacco products on the internet, give someone else money to purchase them, borrow them from someone else, get them from someone who could buy them legally, or get them another way.

Male students were more likely to report that they use cigarettes, cigars, smokeless tobacco, and 2 or more tobacco products when compared with female students. The prevalence of tobacco product use was higher among those in 12th grade than among those in 9th grade.

White and Hispanic students had a higher prevalence of current use of electronic vapor products, cigarettes, any tobacco product, and at least 2 tobacco products when compared with Black students. White students were more likely than Hispanic students to say they used electronic vapor products and any tobacco product.

Youth aged 18 years or older were more likely than students aged 16 or 17 and those aged 15 years or younger to say they currently used cigars. Prevalence rose in each age group for all other individual products, any tobacco product, and multiple tobacco products.

Students who were heterosexual, lesbian, gay, or bisexual were more likely than those who were "not sure" about their sexual identity to report using electronic vapor products. Those who were lesbian, gay, or bisexual were more likely than heterosexual students to currently use cigarettes, cigars, tobacco products, and multiple tobacco products. Any tobacco product use was more common among lesbian, gay, or bisexual students when compared with students unsure of their sexual identity.

Flavored Tobacco Products Driving Much of Increase

Flavored tobacco products, including flavored vaping devices, are responsible for the sharp rise in e-cigarette use. From 2016 through 2017, sales of JUUL, "the most commonly sold e-cigarette in the United States since December 2017," rose approximately 600% (from 2.2 million unit sales to 16.2 million unit sales), the authors write.

By December 2018, three quarters (76%) of the $322.1 million in total e-cigarettes sales during that month in the United States were JUUL products. Several factors likely explain the appeal of these products to youths, including exposure through advertising, the availability of desirable flavors, curiosity, and being around friends and other individuals socially who use the products.

"We need look no further for the cause of this spike than the rise of JUUL and now Puff Flow and Vuse, and the continued sale and proliferation of flavored tobacco products, including flavored vaping devices," Dr Wimmer said.

"The tobacco industry has long used flavored tobacco products as starter products for kids and continues with flavored e-cigarettes today. And these data show that e-cigarette companies, many of which are owned by major tobacco companies, have successfully used Big Tobacco's playbook to hook another generation of America's kids," he continued.

Even infrequent use of tobacco products, and cigarette smoking in particular, is predictive of developing a daily smoking habit, and infrequent use has been associated with nicotine dependence.

"Flavors are known to lure and hook kids to a lifetime of tobacco addiction, and we see this reflected in the continued spike of the amount of youth vaping," Dr Wimmer explained. "To protect kids, the American Lung Association has long called for menthol cigarettes and all flavored tobacco products, including e-cigarettes, to be removed from the marketplace.

"The Food and Drug Administration (FDA) has a unique opportunity to reverse this spike in youth use by denying any flavored tobacco product permission to remain on the market when it reviews the applications due to the agency on September 9. In the meantime, our states and communities must act to fill the void left by FDA's failure to take action by passing state and local laws to prohibit the sale of all flavored tobacco products."

Limitations of the study include changes in the wording of questions in 2017 that make it impossible to compare data from previous years and "long-term trend analyses for prevalence of smokeless tobacco use, any tobacco product use, and use of two or more tobacco products," the authors explain.

The question about how students obtained tobacco products only allowed students to select a single response, but students may have several sources for obtaining the products, and the full scope of their access is unclear.

The findings are part of a larger report on youth risk behavior.

The authors have disclosed no relevant financial relationships.

Morb Mortal Wkly Rep. Published online August 20, 2020.

Survey Highlights

  • From 2017 to 2019, the prevalence of vaping and overall tobacco use doubled among US youth, whereas use of cigarettes and cigars decreased.
  • Implementation of evidence-based tobacco control strategies and FDA regulatory efforts are needed to prevent and reduce all forms of tobacco product use among youths.
  • Members of the health care team should be aware that, regardless of frequency or number of products, use of any tobacco product among youth is unsafe; even infrequent use predicts progression to daily smoking and has been linked to symptoms of nicotine dependence.
  • This analysis of data from US high school students completing the 2019 Youth Risk Behavior Survey examined ever use of cigarettes and electronic vapor products, current use (≥1 day during the 30 days before the survey) of tobacco products, frequent use (≥20 days during the preceding 30 days) among current users of tobacco products, trends in use over time, and usual source of electronic vapor products among current users.
  • In 2019, 50.1% of US high school students had ever used electronic vapor products and 24.1% had ever tried cigarette smoking.
  • The proportion of students reporting current tobacco use was 32.7% for electronic vapor products, 6.0% for cigarettes, 5.7% for cigars, and 3.8% for smokeless tobacco.
  • 36.5% of students were current users of any tobacco product; 8.2% currently used at least 2 products.
  • Frequent use was reported by 32.6% of students for electronic vapor products, 28.5% for smokeless tobacco, 22.2% for cigarettes, and 18.4% for cigars.
  • The most commonly reported source among current electronic vapor product users aged 17 years or younger was borrowing them from someone else (42.8%); other common sources were via the Internet, giving someone else money to purchase them, or getting them from someone who could buy them legally.
  • In contrast, 56.4% of current electronic vapor product users aged 18 years or older reported in-store purchase.
  • There were significant decreases in current cigarette smoking, from 27.5% in 1991 to 8.8% in 2017 and 6.0% in 2019; cigar smoking, from 22.0% in 1997 to 8% in 2017 to 5.7% in 2019; and smokeless tobacco use, from 5.5% in 2017 to 3.8% in 2019.
  • In contrast, current electronic vapor product use increased significantly, from 13.2% in 2017 to 32.7% in 2019, as did current use of any tobacco product, from 19.5% in 2017 to 36.5% in 2019.
  • Students in in 12th grade had higher prevalence of tobacco product use than those in 9th grade.
  • Current cigar use was more prevalent in students aged 18 years or older than in those aged 16 to 17 years and those aged 15 years or younger.
  • For all other individual products, any tobacco product, and multiple tobacco products, prevalence of use increased with increasing age.
  • Males were more likely than females to report use of cigarettes, cigars, smokeless tobacco, and 2 or more tobacco products.
  • Compared with Blacks, Whites and Hispanics had a higher prevalence of current use of electronic vapor products, cigarettes, any tobacco product, and 2 or more tobacco products.
  • Compared with Hispanics, Whites were more likely to report use of electronic vapor products and any tobacco product.
  • Use of electronic vapor products was more likely among students who were heterosexual, lesbian, gay, or bisexual than among those who were unsure of their sexual identity.
  • Compared with heterosexual students, those who were lesbian, gay, or bisexual were more likely to report current use of cigarettes, cigars, any tobacco product, and multiple products.
  • Compared with students unsure of their sexual identity, lesbian, gay, or bisexual students were more likely to report use of any tobacco product.
  • On the basis of their findings, the investigators concluded that the increased prevalence of electronic vapor product use among high school students is concerning, despite decreases in current cigarette smoking, cigar smoking, and smokeless tobacco use.
  • During 2017 to 2019, frequent use of electronic vapor products increased, whereas frequent use of other tobacco products decreased or remained stable.
  • Regardless of frequency or number of products, use of any tobacco product among youth is unsafe.
  • Even infrequent use of tobacco products, particularly cigarettes, predicts progression to daily smoking and has been linked to symptoms of nicotine dependence.
  • Multiple tobacco product use, reported by 8.2% of high school students, is associated with substance use disorders and might increase nicotine exposure and risk for nicotine dependence.
  • Among US youths, the dramatic increase in electronic vapor product use has resulted in increases in overall tobacco product use, erasing gains made in previous years and leading the Surgeon General to declare youth e-cigarette use an epidemic in the United States.
  • Factors encouraging tobacco product use among youths include media exposure to tobacco product advertising and imagery, social interactions with individuals who use the products, curiosity, and especially the availability of flavored tobacco products.
  • Sales of flavored JUUL, the most commonly sold e-cigarette in the United States since December 2017, increased 7-fold from 2016 through 2017, from 2.2 million to 16.2 million unit sales.
  • In December 2018, JUUL products accounted for 76% of the $322.1 million total US e-cigarette sales.
  • An expert consulted by Medscape highlighted the continued sale and proliferation of flavored tobacco products as being largely responsible for the current vaping crisis among youths, noting that the tobacco industry has long used flavored tobacco products as starter products for adolescents.
  • The American Lung Association has therefore called for a ban on marketing menthol cigarettes, flavored e-cigarettes, and all flavored tobacco products.
  • To guide and assess public health policy at the local, state, tribal, and national levels, the investigators recommend continued surveillance for all tobacco product use in this age group.
  • Implementation of evidence-based tobacco control strategies and FDA regulatory efforts are needed to prevent and reduce all forms of tobacco product use among youths.
  • Useful strategies may include increased price of tobacco products, comprehensive smoke-free policies, advertising and promotion restrictions, national antitobacco public education media campaigns, restricting youth access to flavored tobacco products, and increasing the minimum age of purchase for tobacco products from ages 18 to 21 years, which federal legislation did nationwide on December 20, 2019.
  • The National Cancer Institute and the Truth Initiative also offer resources to help youth stop using tobacco products.
  • Study limitations include changes in question wording for smokeless tobacco use from 2017, precluding comparison of 2017 with 2019 and long-term trend analyses; question regarding source of electronic vapor products requiring selection of only single response; and questions related to electronic vapor products and cigars not specifically excluding the possibility of marijuana use in either product.

Clinical Implications

  • From 2017 to 2019, the prevalence of vaping and overall tobacco use doubled among US youth, whereas use of cigarettes and cigars decreased.
  • Implementation of evidence-based tobacco control strategies and FDA regulatory efforts are needed to prevent and reduce all forms of tobacco product use among youths.
  • Implications for the Healthcare Team: Regardless of frequency or number of products, use of any tobacco product among youth is unsafe; even infrequent use predicts progression to daily smoking and has been linked to symptoms of nicotine dependence. Members of the healthcare team should assess teenage patients for vaping and tobacco use and provide cessation related resources when appropriate.

 

Earn Credit

  • Print